PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

York U researchers uncovering how ovarian cancer resists chemotherapy

2011-03-03
(Press-News.org) TORONTO, March 2, 2011 – York University researchers have zeroed in on a genetic process that may allow ovarian cancer to resist chemotherapy.

Researchers in the university's Faculty of Science & Engineering studied a tiny strand of our genetic makeup known as a MicroRNA, involved in the regulation of gene expression. Cancer occurs when gene regulation goes haywire.

"Ovarian cancer is a very deadly disease because it's hard to detect," says biology professor Chun Peng, who co-authored the study. By the time it's diagnosed, usually it is in its late stages. And by that point there's really no way to treat the disease. Even when the disease is discovered in its early stages, chemotherapy doesn't always work," she says.

Peng was among a team of researchers that discovered a receptor, ALK7, that induces cell-death in epithelial ovarian cancer cells. They have now discerned that microRNA 376c targets this crucial receptor, inhibiting its expression and allowing ovarian cancer cells to thrive.

"Our evidence suggests that microRNA 376c is crucial to determining how a patient will respond to a chemotherapeutic agent," says Peng. "It allows cancer cells to survive by targeting the very process that kills them off," she says.

In examining tumours taken from patients who were non-responsive to chemotherapy, researchers found a higher expression of microRNA 376c and a much lower expression of ALK7.

Peng believes that this research is a step towards being able to make chemotherapy drugs more effective in the treatment of the disease.

"Further study is needed, but ultimately if we can introduce anti-microRNAs that would lower the level of those microRNAs that make cancer cells resistant to chemotherapeutic drugs, we will be able to make chemotherapy more effective against ovarian cancer," Peng says.

She urges women to educate themselves about the risk factors and symptoms of the disease. For more information, visit http://www.ovariancanada.org .

Peng is a world expert in the area of ovarian cancer and the molecular basis of complications in pregnancy. Her research on chemo-resistance has also contributed to knowledge and prediction of pre-eclampsia, a pregnancy disorder that is a leading cause of maternal and perinatal complications and death.

The article, "MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance," was published in the Journal of Cell Science.

###

The study's lead author, Gang Ye, is a Research Associate in Peng's lab. Several trainees in Peng's lab, as well as scientists in Toronto's Sunnybrook Research Institute and in China also participated in the project.

The research was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) and a mid-career award to Peng from the Ontario Women's Health Council/CIHR. Ye was supported in part by a Fellowship from the Toronto Ovarian Cancer Research Network.

York University is the leading interdisciplinary research and teaching university in Canada. York offers a modern, academic experience at the undergraduate and graduate level in Toronto, Canada's most international city. The third largest university in the country, York is host to a dynamic academic community of 50,000 students and 7,000 faculty and staff, as well as 200,000 alumni worldwide. York's 10 Faculties and 28 research centres conduct ambitious, groundbreaking research that is interdisciplinary, cutting across traditional academic boundaries. This distinctive and collaborative approach is preparing students for the future and bringing fresh insights and solutions to real-world challenges. York University is an autonomous, not-for-profit corporation.

Media Contact:

Melissa Hughes, Media Relations, York University, 416 736 2100 x22097, mehughes@yorku.ca

END



ELSE PRESS RELEASES FROM THIS DATE:

Solar mystery solved

Solar mystery solved
2011-03-03
The Sun has been in the news a lot lately because it's beginning to send out more flares and solar storms. Its recent turmoil is particularly newsworthy because the Sun was very quiet for an unusually long time. Astronomers had a tough time explaining the extended solar minimum. New computer simulations imply that the Sun's long quiet spell resulted from changing flows of hot plasma within it. "The Sun contains huge rivers of plasma similar to Earth's ocean currents," says Andres Munoz-Jaramillo, a visiting research fellow at the Harvard-Smithsonian Center for Astrophysics ...

Innovation in the Retail Industry: Trends and Technology Top Agenda for Innovate 2011

Innovation in the Retail Industry: Trends and Technology Top Agenda for Innovate 2011
2011-03-03
Retail executives from across the nation will be descending upon San Francisco March 8th-10th for the Retail Advertising & Marketing Association's (RAMA) annual Retail Innovation & Marketing Conference. The show, catered to senior executives in retail e-commerce, marketing and technology, is about the changing business and marketing landscape. RAMA Chairman of the Board and Executive Vice President of Half Price Books, Kathy Doyle Thomas, will be among conference attendees. "This year's conference will showcase the leaders of our industry discussing what they do best: ...

An appeal to the caregiving values of rural women for breast cancer prevention

2011-03-03
KNOXVILLE, TN —March 2, 2011 — In an effort to develop strategies for breast health awareness in rural populations researchers asked the question, "What message strategies will motivate Appalachian women to attend to breast health issues and become actively involved in their own breast health?" A new study published in the Journal of Consumer Affairs finds that two types of reasons motivate rural Appalachian women to perform breast health self-examinations, get mammograms, and to talk with doctors about their breast health. The women articulated their concerns with the ...

NIST, Food Marketing Institute co-host webinar on ensuring accurate net weights in retail

2011-03-03
A reliable and trustworthy system of weights and measures is vital for economic activity. Maintaining that system requires constant vigilance, and that's where the National Institute of Standards and Technology (NIST) Weights and Measures Division (WMD) comes in. While the division routinely hosts meetings and online classes to help state regulators enforce compliance, NIST is now making an effort to reach out to industry and retailers so that they can proactively identify and address problems in their measurement procedures before the regulators show up. Proactive compliance ...

New publication fundamentally changes federal information security risk management

2011-03-03
The National Institute of Standards and Technology (NIST) has published the final version of a special publication that can help organizations to more effectively integrate information security risk planning into their mission-critical functions and overall goals. Managing Information Security Risk: Organization, Mission, and Information System View (NIST Special Publication 800-39) provides the groundwork for a three-tiered, risk-management approach that "fundamentally changes how we manage information security risk at the federal level," says Ron Ross, NIST Fellow and ...

Joint pain in children: Is it just a sore knee, or ... ?

2011-03-03
While lab tests and imaging can sometimes help diagnose juvenile idiopathic arthritis (JIA), a physical examination and thorough patient history are the most valuable tools in identifying this disease. According to a new literature review from the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), the rate of false positives in laboratory evaluations and imaging studies meant to screen for juvenile arthritis makes their value limited. Juvenile idiopathic arthritis (formerly known as juvenile rheumatoid arthritis) is an autoimmune disease that affects nearly ...

Penn physicists develop scalable method for making graphene

2011-03-03
PHILADELPHIA — New research from the University of Pennsylvania demonstrates a more consistent and cost-effective method for making graphene, the atomic-scale material that has promising applications in a variety of fields, and was the subject of the 2010 Nobel Prize in Physics. As explained in a recently published study, a Penn research team was able to create high-quality graphene that is just a single atom thick over 95% of its area, using readily available materials and manufacturing processes that can be scaled up to industrial levels. "I'm aware of reports of ...

Study in PLoS: Intensive adherence counseling to HIV treatment improves patient outcomes

2011-03-03
Intensive adherence counseling around the time of HIV treatment initiation significantly reduces poor adherence and virologic treatment failure in sub-Saharan Africa, according to a recent study in PLoS Medicine by Dr. Michael Chung, assistant professor of Global Health at University of Washington, who works at the Coptic Hope Center for Infectious Diseases in Nairobi, Kenya. The study published March 1 also found that using an alarm device has no effect on adherence counseling. The findings of this study define an adherence counseling protocol that is effective and ...

Lithosphere: New research posted Feb. 10

2011-03-03
Boulder, CO, USA - LITHOSPHERE is now regularly posting pre-issue publication content -- finalized papers ready to go to press and not under embargo. GSA invites you to sign up for e-alerts and/or RSS feeds to have access to new journal content the minute it is posted online. Go to http://www.gsapubs.org/cgi/alerts and enter your e-mail address to manage your subscriptions for pre-issue postings, tables of contents alerts, and more. The following LITHOSPHERE articles were published online 10 Feb. 2011. Mafic granulite xenoliths from the East Indian Shield: Evidence ...

Nature study: Jefferson researchers unravel protein's elusive role in embryo and disease development

2011-03-03
PHILADELPHIA—Reporting in Nature, scientists from Thomas Jefferson University have determined that a single protein called FADD controls multiple cell death pathways, a discovery that could lead to better, more targeted autoimmune disease and cancer drugs. Twelve years ago, internationally-known immunologist Jianke Zhang, Ph.D., an associate professor in the Department of Microbiology and Immunology at Thomas Jefferson University, realized FADD, which stands for Fas-Associated protein with Death Domain, played an important role in embryonic development and the onset of ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] York U researchers uncovering how ovarian cancer resists chemotherapy